These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 23507280)
1. Semen-derived enhancer of viral infection (SEVI) binds bacteria, enhances bacterial phagocytosis by macrophages, and can protect against vaginal infection by a sexually transmitted bacterial pathogen. Easterhoff D; Ontiveros F; Brooks LR; Kim Y; Ross B; Silva JN; Olsen JS; Feng C; Hardy DJ; Dunman PM; Dewhurst S Antimicrob Agents Chemother; 2013 Jun; 57(6):2443-50. PubMed ID: 23507280 [TBL] [Abstract][Full Text] [Related]
2. SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells. Elias AK; Scanlon D; Musgrave IF; Carver JA Biochim Biophys Acta; 2014 Sep; 1844(9):1591-8. PubMed ID: 24948476 [TBL] [Abstract][Full Text] [Related]
3. Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide. Olsen JS; DiMaio JT; Doran TM; Brown C; Nilsson BL; Dewhurst S J Biol Chem; 2012 Apr; 287(15):11842-9. PubMed ID: 22354963 [TBL] [Abstract][Full Text] [Related]
4. The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI). Elias AK; Wilson MR; Carver JA; Musgrave IF Cells; 2022 Oct; 11(20):. PubMed ID: 36291126 [TBL] [Abstract][Full Text] [Related]
5. Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection. Tan S; Lu L; Li L; Liu J; Oksov Y; Lu H; Jiang S; Liu S PLoS One; 2013; 8(3):e59777. PubMed ID: 23544097 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of semen-derived enhancer of virus infection (SEVI) fibrillogenesis by zinc and copper. Sheftic SR; Snell JM; Jha S; Alexandrescu AT Eur Biophys J; 2012 Sep; 41(9):695-704. PubMed ID: 22907203 [TBL] [Abstract][Full Text] [Related]
7. Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity. Ren R; Yin S; Lai B; Ma L; Wen J; Zhang X; Lai F; Liu S; Li L Retrovirology; 2018 Jul; 15(1):49. PubMed ID: 30012153 [TBL] [Abstract][Full Text] [Related]
9. Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection. Arnold F; Schnell J; Zirafi O; Stürzel C; Meier C; Weil T; Ständker L; Forssmann WG; Roan NR; Greene WC; Kirchhoff F; Münch J J Virol; 2012 Jan; 86(2):1244-9. PubMed ID: 22090109 [TBL] [Abstract][Full Text] [Related]
10. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Kim KA; Yolamanova M; Zirafi O; Roan NR; Staendker L; Forssmann WG; Burgener A; Dejucq-Rainsford N; Hahn BH; Shaw GM; Greene WC; Kirchhoff F; Münch J Retrovirology; 2010 Jun; 7():55. PubMed ID: 20573198 [TBL] [Abstract][Full Text] [Related]
11. ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection. Xun T; Li W; Chen J; Yu F; Xu W; Wang Q; Yu R; Li X; Zhou X; Lu L; Jiang S; Li L; Tan S; Liu S Antimicrob Agents Chemother; 2015 Sep; 59(9):5123-34. PubMed ID: 26055369 [TBL] [Abstract][Full Text] [Related]
12. NMR structure in a membrane environment reveals putative amyloidogenic regions of the SEVI precursor peptide PAP(248-286). Nanga RP; Brender JR; Vivekanandan S; Popovych N; Ramamoorthy A J Am Chem Soc; 2009 Dec; 131(49):17972-9. PubMed ID: 19995078 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 enhancing effect of prostatic acid phosphatase peptides is reduced in human seminal plasma. Martellini JA; Cole AL; Svoboda P; Stuchlik O; Chen LM; Chai KX; Gangrade BK; Sørensen OE; Pohl J; Cole AM PLoS One; 2011 Jan; 6(1):e16285. PubMed ID: 21283773 [TBL] [Abstract][Full Text] [Related]
14. Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection). Roan NR; Sowinski S; Münch J; Kirchhoff F; Greene WC J Biol Chem; 2010 Jan; 285(3):1861-9. PubMed ID: 19897482 [TBL] [Abstract][Full Text] [Related]
15. Semen-derived amyloidogenic peptides-Key players of HIV infection. Lee YH; Ramamoorthy A Protein Sci; 2018 Jul; 27(7):1151-1165. PubMed ID: 29493036 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the Influence of Semen-Derived Enhancer of Virus Infection on the Interaction of HIV-1 with Female Reproductive Tract Tissues. Allen SA; Carias AM; Anderson MR; Okocha EA; Benning L; McRaven MD; Kelley ZL; Lurain J; Veazey RS; Hope TJ J Virol; 2015 May; 89(10):5569-80. PubMed ID: 25740984 [TBL] [Abstract][Full Text] [Related]
18. Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection. Olsen JS; Brown C; Capule CC; Rubinshtein M; Doran TM; Srivastava RK; Feng C; Nilsson BL; Yang J; Dewhurst S J Biol Chem; 2010 Nov; 285(46):35488-96. PubMed ID: 20833717 [TBL] [Abstract][Full Text] [Related]
19. SEVI Inhibits Aβ Amyloid Aggregation by Capping the β-Sheet Elongation Edges. Wang Y; Xu J; Huang F; Yan J; Fan X; Zou Y; Wang C; Ding F; Sun Y J Chem Inf Model; 2023 Jun; 63(11):3567-3578. PubMed ID: 37246935 [TBL] [Abstract][Full Text] [Related]
20. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection. Hauber I; Hohenberg H; Holstermann B; Hunstein W; Hauber J Proc Natl Acad Sci U S A; 2009 Jun; 106(22):9033-8. PubMed ID: 19451623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]